117 related articles for article (PubMed ID: 11757473)
1. [Anti-ischemic efficacy of sustained-release isosorbide-5-mononitrate: echocardiography during mental and physical stress].
Keck M; Tretter R; Sauerbrey-Wullkopf N
Z Kardiol; 2001 Oct; 90(10):766-73. PubMed ID: 11757473
[TBL] [Abstract][Full Text] [Related]
2. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
3. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
4. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
[TBL] [Abstract][Full Text] [Related]
5. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
Nordlander R; Walter M
Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
7. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Akhras F; Chambers J; Jefferies S; Jackson G
Int J Cardiol; 1989 Aug; 24(2):191-6. PubMed ID: 2504673
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release IS-5-MN in the treatment of coronary heart disease.
Keck M
Cardiology; 1991; 79 Suppl 2():51-7. PubMed ID: 1760831
[TBL] [Abstract][Full Text] [Related]
9. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.
Parker JO
Am J Cardiol; 1993 Oct; 72(12):871-6. PubMed ID: 8213541
[TBL] [Abstract][Full Text] [Related]
10. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
Krepp HP
Cardiology; 1991; 79 Suppl 2():14-8. PubMed ID: 1760823
[TBL] [Abstract][Full Text] [Related]
13. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
15. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
Thadani U
Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of isosorbide-5-mononitrate retard in patients with stable exertional angina].
Demin AA; Aksenova EA
Klin Med (Mosk); 2005; 83(9):53-6. PubMed ID: 16279042
[TBL] [Abstract][Full Text] [Related]
17. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
18. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
19. [Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form].
Erlemeier HH; Kupper W; Lange S; Bleifeld W
Z Kardiol; 1986; 75 Suppl 3():112-4. PubMed ID: 3541415
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]